BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3084067)

  • 1. Macrophage-mediated induction of drug-resistant variants in a mouse mammary tumor cell line.
    Yamashina K; Miller BE; Heppner GH
    Cancer Res; 1986 May; 46(5):2396-401. PubMed ID: 3084067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Macrophage-mediated induction of drug-resistance variants in a mouse mammary tumor cell line].
    Yamashina K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):568-75. PubMed ID: 3758918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-mediated induction of DNA strand breaks in target tumor cells.
    Chong YC; Heppner GH; Paul LA; Fulton AM
    Cancer Res; 1989 Dec; 49(23):6652-7. PubMed ID: 2819715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor.
    Yamashina K; Heppner GH
    Cancer Res; 1985 Sep; 45(9):4015-9. PubMed ID: 4027998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMS.
    Knaap AG; Simons JW
    Mutat Res; 1975 Oct; 30(1):97-110. PubMed ID: 1237086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative selectivity of contact-mediated intercellular communication in a metastatic mouse mammary tumor line.
    Miller BE; Roi LD; Howard LM; Miller FR
    Cancer Res; 1983 Sep; 43(9):4102-7. PubMed ID: 6871851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basis for differential cellular sensitivity to 8-azaguanine and 6-thioguanine.
    van Diggelen OP; Donahue TF; Shin SI
    J Cell Physiol; 1979 Jan; 98(1):59-71. PubMed ID: 762202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversion in expression of hypoxanthine-guanine phosphoribosyltransferase in 6-thioguanine resistant neuroblastoma: evidence for reduced enzyme levels associated with unaltered catalytic activity.
    Skaper SD; Spector EB; Seegmiller JE
    J Cell Physiol; 1977 Aug; 92(2):275-83. PubMed ID: 18484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.
    Parris CN; Walker MC; Masters JR; Arlett CF
    Cancer Res; 1990 Dec; 50(23):7513-8. PubMed ID: 2253200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
    Hoon DB; Ziola B; Ramshaw I
    Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of thioguanine-resistant mutations in human uroepithelial cells by 4-aminobiphenyl and its N-hydroxy derivatives.
    Bookland EA; Reznikoff CA; Lindstrom M; Swaminathan S
    Cancer Res; 1992 Mar; 52(6):1615-21. PubMed ID: 1311636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Thioguanine resistant T-lymphocyte determination as a possible indicator of human ionizing radiation exposure.
    Ostrosky-Wegman P; Montero R; Cortinas de Nava C; Hurtado F
    Bol Estud Med Biol; 1989; 37(3-4):77-81. PubMed ID: 2633789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
    Begleiter A; Leith MK; McClarty G; Beenken S; Goldenberg GJ; Wright JA
    Cancer Res; 1988 Apr; 48(7):1727-35. PubMed ID: 3127038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 6-thioguanine-resistant mutation and sister chromatid exchanges in Chinese hamster V79 cells with forty chemical and physical agents.
    Nishi Y; Hasegawa MM; Taketomi M; Ohkawa Y; Inui N
    Cancer Res; 1984 Aug; 44(8):3270-9. PubMed ID: 6744262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
    Loveless SE; Heppner GH
    J Immunol; 1983 Oct; 131(4):2074-8. PubMed ID: 6619548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric enumeration of drug-resistant tumor cells.
    deFazio A; Musgrove EA; Tattersall MH
    Cancer Res; 1988 Nov; 48(21):6037-43. PubMed ID: 3167854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hypoxanthine phosphoribosyltransferase deficiency in human U-937 cells.
    Radzun HJ; Parwaresch MR; Kreipe H
    J Natl Cancer Inst; 1986 Feb; 76(2):201-6. PubMed ID: 3456059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities.
    Baskin F; Rosenberg RN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):293-300. PubMed ID: 1169317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.